Screening for VPS35 mutations in Parkinson's disease

Neurobiology of Aging

Volumn 33, Issue 4, 2012, Pages 838.e1-838.e5

  Sheerin, Una Marie ^a   Charlesworth, Gavin ^a   Bras, Jose ^a   Guerreiro, Rita ^a   Bhatia, Kailash ^a   Foltynie, Thomas ^a   Limousin, Patricia ^a   Silveira Moriyama, Laura ^b   Lees, Andrew ^a   Wood, Nicholas ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Genetics; Parkinson's disease; Population screening; VPS35

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; BALANCE IMPAIRMENT; BRADYKINESIA; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; COUSIN; DEPRESSION; DYSKINESIA; EXON; FAMILY; FAMILY STUDY; FEMALE; GENE; GENE MUTATION; GENETIC VARIABILITY; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PALLIDOTOMY; PARKINSON DISEASE; PARKINSONISM; PEDIGREE; PRIORITY JOURNAL; SIBLING; TREATMENT RESPONSE; TREMOR; VPS35 GENE;

EID: 84856956020     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.10.032     Document Type: Article

References (27)

1. Alcalay R.N., Siderowf A., Ottman R., Caccappolo E., Mejia-Santana H., Tang M.X., Rosado L., Louis E., Ruiz D., Waters C., Fahn S., Cote L., Frucht S., Ford B., Orbe-Reilly M., Ross B., Verbitsky M., Kisselev S., Comella C., Colcher A., Jennings D., Nance M., Bressman S., Scott W.K., Tanner C., Mickel S., Rezak M., Novak K.E., Friedman J.H., Pfeiffer R., Marsh L., Hiner B., Clark L.N., Marder K. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology 2011, 76:319-326.
2. Arighi C.N., Hartnell L.M., Aguilar R.C., Haft C.R., Bonifacino J.S. Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor. J. Cell Biol 2004, 165:123-133.
3. Bonifacino J.S., Hurley J.H. Retromer. Curr. Opin. Cell Biol 2008, 20:427-436.
4. Bonifacino J.S., Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat. Rev. Mol. Cell Biol 2006, 7:568-579.
5. Bonifati V., Rizzu P., Van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., Van Dongen J.W., Vanacore N., Van Swieten J.C., Brice A., Meco G., Van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
6. Braak H., Del Tredici K., Rüb U., De Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
7. Doty R.L., Shaman P., Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol. Behav 1984, 32:489-502.
8. Healy D.G., Falchi M., O'Sullivan S.S., Bonifati V., Durr A., Bressman S., Brice A., Aasly J., Zabetian C.P., Goldwurm S., Ferreira J.J., Tolosa E., Kay D.M., Klein C., Williams D.R., Marras C., Lang A.E., Wszolek Z.K., Berciano J., Schapira A.H.V., Lynch T., Bhatia K.P., Gasser T., Lees A.J., Wood N.W. International LRRK2 Consortium, Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008, 7:583-590.
9. Ince P.G., Clark B., Holton J.L., Revesz T., Wharton S. Disorders of movement and system degenerations. Greenfield's Neuropathology 2008, 889-981. Arnold, London, Chapter13. eighth ed. S. Love, D.N. Louis, D.W. Ellison (Eds.).
10. Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simón-Sánchez J., Schulte C., Lesage S., Sveinbjörnsdóttir S., Stefánsson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649. International Parkinson Disease Genomics Consortium.
11. A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease. PLoS Genet 2011, 2011:e1002142. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2).
12. Khan N.L., Katzenschlager R., Watt H., Bhatia K.P., Wood N.W., Quinn N., Lees A.J. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology 2004, 62:1224-1226.
13. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
14. Mayeux R., Marder K., Cote L.J., Denaro J., Hemenegildo N., Mejia H., Tang M.X., Lantigua R., Wilder D., Gurland B., et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am. J. Epidemiol 1995, 142:820-827.
15. Nielsen M.S., Gustafsen C., Madsen P., Nyengaard J.R., Hermey G., Bakke O., Mari M., Schu P., Pohlmann R., Dennes A., Petersen C.M. Sorting by the cytoplasmic domain of the amyloid precursor protein binding receptor SorLA. Mol. Cell. Biol 2007, 27:6842-6851.
16. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simón J., Van Der Brug M., López De Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., De Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
17. Poewe W., Mahlknecht P. The clinical progression of Parkinson's disease. Parkinsonism Relat. Disord 2009, 15(Suppl 4):S28-S32.
18. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
19. Saunders-Pullman R., Stanley K., Wang C., San Luciano M., Shanker V., Hunt A., Severt L., Raymond D., Ozelius L.J., Lipton R.B., Bressman S.B. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 2011, 77:319-324.
20. Seaman M.N. Recycle your receptors with retromer. Trends Cell Biol 2005, 15:68-75.
21. Silveira-Moriyama L., Guedes L.C., Kingsbury A., Ayling H., Shaw K., Barbosa E.R., Bonifati V., Quinn N.P., Abou-Sleiman P., Wood N.W., Petrie A., Sampaio C., Ferreira J.J., Holton J., Revesz T., Lees A.J. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 2008, 71:1021-1026.
22. Silveira-Moriyama L., Munhoz R.P., De J Carvalho M., Raskin S., Rogaeva E., De C Aguiar P., Bressan R.A., Felicio A.C., Barsottini O.G.P., Andrade L.A., Chien H.F., Bonifati V., Barbosa E.R., Teive H.A., Lees A.J. Olfactory heterogeneity in LRRK2 related Parkinsonism. Mov. Disord 2010, 25:2879-2883.
23. Silveira-Moriyama L., Petrie A., Williams D.R., Evans A., Katzenschlager R., Barbosa E.R., Lees A.J. The use of a color coded probability scale to interpret smell tests in suspected parkinsonism. Mov. Disord 2009, 24:1144-1153.
24. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., González-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
25. Vilariño-Güell C., Wider C., Ross O.A., Dachsel J.C., Kachergus J.M., Lincoln S.J., Soto-Ortolaza A.I., Cobb S.A., Wilhoite G.J., Bacon J.A., Behrouz B., Melrose H.L., Hentati E., Puschmann A., Evans D.M., Conibear E., Wasserman W.W., Aasly J.O., Burkhard P.R., Djaldetti R., Ghika J., Hentati F., Krygowska-Wajs A., Lynch T., Melamed E., Rajput A.H., Rajput A.H., Solida A., Wu R.-M., Uitti R.J., Wszolek Z.K., Vingerhoets F., Farrer M.J. VPS35 Mutations in Parkinson Disease. Am. J. Hum. Genet 2011, 89:162-167.
26. Zimprich A., Benet-Pagès A., Struhal W., Graf E., Eck S.H., Offman M.N., Haubenberger D., Spielberger S., Schulte E.C., Lichtner P., Rossle S.C., Klopp N., Wolf E., Seppi K., Pirker W., Presslauer S., Mollenhauer B., Katzenschlager R., Foki T., Hotzy C., Reinthaler E., Harutyunyan A., Kralovics R., Peters A., Zimprich F., Brücke T., Poewe W., Auff E., Trenkwalder C., Rost B., Ransmayr G., Winkelmann J., Meitinger T., Strom T.M. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet 2011, 89:168-175.
27. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.